Cargando…

Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?

Objective: This study aims to examine the efficacy and safety of the antitumor necrosis factor (TNF) drugs in ankylosing spondylitis (AS) patients with chronic kidney disease. Methods: In this study, 24 male patients with a glomerular filtration rate (GFR) of <60 mL min(−1) 1.73 m(−2) were includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coşkun, Belkıs Nihan, Yağız, Burcu, Gündüz Çorabay, Seniha, Pehlivan, Yavuz, Dalkılıç, Ediz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medical Research and Education Association 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176218/ https://www.ncbi.nlm.nih.gov/pubmed/35546331 http://dx.doi.org/10.5152/eurjrheum.2022.21099

Ejemplares similares

Attitudes of patients with a rheumatic disease on drug use in the COVID-19 pandemic
por: Coskun, Belkıs Nihan, et al.
Publicado: (2021)

The effects of COVID-19 infection on the mortality of patients receiving rituximab therapy
por: Ekin, Ali, et al.
Publicado: (2022)

Are nonsteroidal anti-inflammatory drugs safe for the kidney in ankylosing spondylitis?
por: Kim, Ji-Won
Publicado: (2023)

Anti-TNF-α Therapy for Ankylosing Spondylitis
por: Son, Jung-Hwan, et al.
Publicado: (2010)

The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database
por: Alpay Kanıtez, Nilüfer, et al.
Publicado: (2022)

Association of anti-TNF-α treatment with gut microbiota of patients with ankylosing spondylitis
por: Dai, Qinghong, et al.
Publicado: (2022)

TNF-alpha antagonists for treatment of juvenile ankylosing spondylitis
por: Orbán, I, et al.
Publicado: (2011)

Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment
por: Batko, Bogdan, et al.
Publicado: (2018)

The relationship of ischemia-modified albumin levels to disease activity scores and HLA-B27 in patients with ankylosing spondylitis
por: Sertpoyraz, Filiz Meryem, et al.
Publicado: (2020)

Influence of anti-TNF-α treatment on liver and kidney functions in patients with ankylosing spondylitis: A retrospective longitudinal study
por: Akyol, Lütfi, et al.
Publicado: (2022)

Anti‐TNF‐α therapy alters the gut microbiota in proteoglycan‐induced ankylosing spondylitis in mice
por: Liu, Bin, et al.
Publicado: (2019)

Associations of Platelet Count with Inflammation and Response to Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis
por: Qian, Hongyan, et al.
Publicado: (2020)

Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients
por: Soós, Boglárka, et al.
Publicado: (2022)

The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study
por: Swart, I. A. P., et al.
Publicado: (2022)

Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy
por: TÜRK, Sümeyye Merve, et al.
Publicado: (2021)

Use of the Oswestry Disability Index in ankylosing spondylitis
por: Aytekin, Ebru, et al.
Publicado: (2023)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor Therapy
por: Ou, Jiayong, et al.
Publicado: (2021)

Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic
por: KALYONCU, Umut, et al.
Publicado: (2021)

Anti-TNF Therapy Regulates Phagosome Pathway by Inhibiting NCF4 Expression to Treat Ankylosing Spondylitis
por: Liu, Sha, et al.
Publicado: (2023)

Serum chitotriosidase and neopterin levels in patients with ankylosing spondylitis
por: Yavuz, Ferdi, et al.
Publicado: (2019)

Genome-wide association study in Turkish and Iranian populations identify rare familial Mediterranean fever gene (MEFV) polymorphisms associated with ankylosing spondylitis
por: Li, Zhixiu, et al.
Publicado: (2019)

Safe Re-administration of Tumor Necrosis Factor-alpha (TNFα) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFα Therapy
por: Suh, Young Sun, et al.
Publicado: (2014)

Reparative radiological changes of hip joint after TNF inhibitors in ankylosing spondylitis
por: Maatallah, Kaouther, et al.
Publicado: (2018)

Machine learning to predict early TNF inhibitor users in patients with ankylosing spondylitis
por: Lee, Seulkee, et al.
Publicado: (2020)

Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells
por: Schramm-Luc, Agata, et al.
Publicado: (2018)

Imaging of ankylosing spondylitis
por: Østergaard, Mikkel
Publicado: (2012)

Alexithymia in ankylosing spondylitis
por: Karabıçak, Deniz, et al.
Publicado: (2021)

Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register
por: Lord, Paul A. C., et al.
Publicado: (2010)

Rituximab Can Induce Remission in a Patient with Ankylosing Spondylitis Who Failed Anti-TNF-α Agent
por: AlDhaheri, Fahmi, et al.
Publicado: (2017)

A prospective clinical investigation of the effects of anti-TNF alpha therapy on exercise capacity in patients with ankylosing spondylitis
por: ÇAPKIN, Erhan, et al.
Publicado: (2019)

Common Mediterranean Fever (MEFV) Gene Mutations Associated with Ankylosing Spondylitis in Turkish Population
por: Yigit, Serbulent, et al.
Publicado: (2012)

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
por: Baraliakos, Xenofon, et al.
Publicado: (2005)

Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-α therapy and other novel approaches
por: Braun, Juergen, et al.
Publicado: (2002)

IGF-1 and ADMA Levels Are Inversely Correlated in Nondiabetic Ankylosing Spondylitis Patients Undergoing Anti-TNF-Alpha Therapy
por: Genre, Fernanda, et al.
Publicado: (2014)

Immunological Changes in Peripheral Blood of Ankylosing Spondylitis Patients during Anti-TNF-α Therapy and Their Correlations with Treatment Outcomes
por: Chen, Rongjuan, et al.
Publicado: (2021)

Effectiveness of a supervised group exercise therapy based on the biopsychosocial model introduced simultaneously with anti-TNF therapy in anti-TNF-naive patients with active ankylosing spondylitis
por: KARACA, Nur Banu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cdfh7hgb94aotnb2i7ucjufi9i